CRA and CRC roles in clinical research
Two roles appear in almost every clinical trial: the Clinical Research Associate (CRA) and the Clinical Research Coordinator (CRC). They work towards the same overall goal but from very different positions and with different day-to-day responsibilities, and the split between them isn't arbitrary. It largely follows the sponsor and investigator responsibilities set out in ICH E6(R2), with the CRA acting as the sponsor's monitoring representative and the CRC supporting the investigator's delegated responsibilities at the site.
Who they work for
A CRA works on behalf of the sponsor: a pharmaceutical company, biotech, or CRO. They move between trial sites and are primarily concerned with whether the study is running according to protocol and regulatory standards. A CRC is employed by the site itself, often a hospital or university, and works at a single location managing the study on the ground.
What they do day to day
CRA responsibilities:
- Conducting site visits and monitoring study progress
- Reviewing source documents and verifying data in electronic systems
- Identifying protocol deviations and escalating where necessary
- Ensuring regulatory compliance across their portfolio of sites
CRC responsibilities:
- Recruiting participants and managing the consent process
- Collecting data and coordinating between investigators and participants
- Handling the operational logistics of each study day at the site
- Serving as the main point of contact for participants throughout their involvement
Where their focus sits
CRAs are primarily concerned with data quality and compliance across multiple sites. Their job is to ensure that what is happening at each site matches what was intended in the protocol and what regulators expect to see.
CRCs are primarily concerned with execution at one location: keeping participants safe, completing tasks correctly, and making sure the site's contribution to the study is clean and complete.
It's worth noting that neither role's scope is fixed forever. As decentralised and hybrid trial designs become more common, some of what a CRC would traditionally have done in person is shifting toward remote coordination, and some of what a CRA would have verified on-site is increasingly checked through centralised, systems-based monitoring instead. The underlying division of responsibility, sponsor oversight versus site-level execution, hasn't disappeared. The specific tasks sitting on each side of that line are simply moving as the tools available to do the work change.
The two roles, side by side
| CRA | CRC | |
|---|---|---|
| Employed by | Sponsor or CRO | Site (hospital, university, clinic) |
| Scope | Multiple sites, one or more studies | One site, often multiple studies |
| Primary relationship | With CRCs and principal investigators | With participants and site staff |
| Core question they're answering | Does this site match the protocol and regulatory expectations? | Is this participant's visit today handled correctly, safely, and completely? |
| Regulatory grounding | ICH E6(R2), Section 5 (sponsor) | ICH E6(R2), Section 4 (investigator, delegated) |
How they interact
CRAs spend most of their time working with CRCs and principal investigators. CRCs spend most of their time with participants and site staff. When a monitoring visit happens, the CRA and CRC are each other's main interface, and the quality of that specific relationship often determines how smoothly a site runs more broadly. A CRA who treats every visit as an adversarial audit and a CRC who treats every query as an attack on their competence will both make the other's job harder than it needs to be. The most effective pairings tend to treat monitoring as a shared problem-solving exercise rather than an inspection one party is subjected to by the other.
The skills each role requires
CRAs need a strong grounding in GCP, clinical trial regulations, and monitoring methodology, along with the project management capability to handle multiple sites in parallel. CRCs typically have a clinical or administrative background, strong interpersonal skills, and the organisational capacity to manage multiple study tasks and participant relationships simultaneously.
Both roles are essential. Neither succeeds without the other working well, and the ICH-GCP framework underlying both was written with exactly that mutual dependency in mind: a sponsor's oversight is only as good as what a well-supported CRC can actually deliver at the point of contact with a participant, and a CRC's local excellence only counts for the study as a whole if a CRA is genuinely verifying and documenting it consistently across every site involved.